Reduced fluence photodynamic therapy combined with intravitreal anti-vascular endothelial growth factor antibody for age-related macular degeneration.
Not Applicable
- Conditions
- Age-related macular degeneration
- Registration Number
- JPRN-UMIN000004562
- Lead Sponsor
- Yamagata University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
the patient without exudative changes in fundus.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method vision acuity, disapearment of neovascularization.
- Secondary Outcome Measures
Name Time Method